ReposiTrak Posts 16% Revenue Growth, 27% Net Income Increase, and $0.10 EPS for Q3 2025

Reuters
2025/05/20
<a href="https://laohu8.com/S/TRAK">ReposiTrak</a> Posts 16% Revenue Growth, 27% Net Income Increase, and $0.10 EPS for Q3 2025

ReposiTrak Inc., the world's largest food traceability and regulatory compliance network, reported a 16% increase in total revenue for the third fiscal quarter of 2025, amounting to $5.9 million compared to $5.1 million in the same quarter of the previous year. The company highlighted that 98% of this revenue was recurring. Operating expenses for the quarter rose by 7% to $4.1 million, up from $3.8 million last year. Net income for the quarter increased by 27% to $2.0 million, compared to $1.6 million in the third quarter of the prior year. Net income to common shareholders also saw a significant rise of 33%, reaching $1.9 million from $1.4 million the previous year. The company reported a diluted earnings per share $(EPS)$ of $0.10, an improvement from $0.08 in the previous year's third fiscal quarter. ReposiTrak also announced that during the quarter, they redeemed 70,093 preferred shares at a redemption price of $10.70 per share, totaling $749,995, and paid $331,000 in cash dividends to common shareholders. The company ended the quarter with over $28.1 million in cash and no bank debt, demonstrating strong financial stability.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Repositrak Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-017612), on May 19, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10